Respiratory Role in Acid-Base Balance
A marathon runner's blood pH drifts by barely 0.1 units. This happens even as her muscles dump lactic acid into circulation at a furious rate. How does the body defend such a narrow range while metabolism churns out acid every second? The answer lies in a partnership between chemistry and physiology. It is a buffer reaction that is uniquely "open." One of its products — carbon dioxide — is a gas. The lungs can vent this gas to the atmosphere within minutes. This coupling of a chemical equilibrium to a ventilatory pump matters greatly. It allows arterial pH to be held between 7.35 and 7.45. This happens despite continuous acid production. Acid-base balance matters because nearly every protein's shape depends on pH. That shape, and therefore function, depends on the protonation state of its amino acid side chains. Enzymes, ion channels, hemoglobin's oxygen affinity, and neuromuscular excitability all shift. This happens when pH strays outside its narrow physiological window. Death typically occurs if arterial pH falls below about 6.8. It also occurs if arterial pH rises above about 7.8. The respiratory system is one of three lines of defense. The others are chemical buffers and the kidney. The respiratory system is by far the fastest of the three. It corrects a disturbance within minutes. Buffers take hours, and renal compensation takes days. The big picture is this: CO2 is produced by aerobic metabolism. It combines with water to form carbonic acid. This acid dissociates into a proton and bicarbonate. The lungs continuously remove CO2. Because of this, they effectively control the numerator of the Henderson-Hasselbalch equation for this buffer pair. This gives the respiratory system leverage over blood pH. That leverage is disproportionate to its modest chemical contribution. This article builds the mechanism of that leverage. It starts from the enzymatic hydration of CO2 in the erythrocyte. It continues through the chemoreceptor reflex arcs that adjust ventilation. The article also reviews the classical evidence for how this system works. This evidence ranges from Henderson's physical chemistry to clinical acid-base nomograms. It closes by connecting the concept to Respiratory Adaptations. These adaptations are seen in altitude, exercise, and disease.
- CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3⁻ is the body's dominant buffer pair because CO2, the acid precursor, is volatile and lung-controlled.
- The Henderson-Hasselbalch equation shows blood pH depends on the ratio of [HCO3⁻] to arterial PCO2, not on their absolute amounts.
- Central chemoreceptors near the medulla sense CSF [H+], which is set by arterial PCO2 crossing the blood-brain barrier as CO2, not by [H+] itself.
- Peripheral chemoreceptors (carotid bodies) sense arterial pH, PCO2, and PO2 directly in the blood and respond faster but contribute less to baseline drive.
- Respiratory compensation for a metabolic disturbance is fast (minutes) but only partial; full correction requires renal adjustment of [HCO3⁻] over 1-3 days.
- Primary respiratory acid-base disorders (hypo/hyperventilation) are compensated by the kidney changing bicarbonate reabsorption and net acid excretion.
Because CO2 is the volatile precursor of carbonic acid, ventilation gives the lungs second-by-second control over the [HCO3⁻]/PCO2 ratio that the Henderson-Hasselbalch equation says determines blood pH.
The core idea
Acid-base physiology rests on one deceptively simple reaction, catalyzed reversibly by the enzyme carbonic anhydrase: CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3⁻ This is the bicarbonate buffer system, and it is the most important buffer in extracellular fluid — not because it has an especially favorable pKa (its pKa of 6.1 is actually far from physiological pH 7.4, which would make it a poor buffer by classical chemistry), but because it is an open system. One of the equilibrium's reactants, CO2, is a gas continuously produced by tissue metabolism and continuously removed by the lungs. This means the lungs can adjust the CO2 side of the equation independently of the kidneys' adjustment of the HCO3⁻ side, giving the body two independent handles on the same buffer pair. The relationship is captured quantitatively by the Henderson-Hasselbalch equation: pH = pK + log ([HCO3⁻] / (0.03 × PaCO2)) where 0.03 is the solubility coefficient for CO2 in plasma (mmol/L per mmHg), pK is 6.1, [HCO3⁻] is expressed in mmol/L, and PaCO2 in mmHg. Plugging in normal values —
| Variable | Normal value |
|---|---|
| [HCO3⁻] | 24 mmol/L |
| PaCO2 | 40 mmHg |
| Arterial pH | 7.40 |
— gives pH = 6.1 + log(24 / (0.03×40)) = 6.1 + log(20) = 6.1 + 1.3 = 7.4. The number 20 (the ratio of HCO3⁻ to dissolved CO2) is the single most important number in acid-base physiology: as long as the kidney and lungs cooperate to keep this ratio near 20:1, pH stays near 7.4, regardless of the absolute values of the numerator and denominator. This is why the respiratory system is described as controlling the denominator and the kidney the numerator. A rise in PaCO2 (hypoventilation) drives the equilibrium rightward, generating more H+ and HCO3⁻ and lowering pH — a respiratory acidosis. A fall in PaCO2 (hyperventilation) does the reverse, producing respiratory alkalosis. Conversely, a change in [HCO3⁻] from a non-respiratory (metabolic) cause — say, added lactic acid consuming bicarbonate — is a metabolic acidosis, and the respiratory system compensates by hyperventilating to blow off CO2 and partially restore the ratio. Understanding this article requires the CO2 transport chemistry (bicarbonate formation in red cells, the chloride shift) and the ventilatory control circuitry (central and peripheral chemoreceptors) covered under Carbon Dioxide Transport and Control of Ventilation; here we integrate them into a single homeostatic feedback loop.
Mechanism
Step 1 — CO2 production and diffusion into blood. Aerobic metabolism in tissues produces roughly 200 mL CO2 per minute at rest (a respiratory quotient near 0.8, meaning CO2 production is somewhat less than O2 consumption). This CO2 diffuses down its partial pressure gradient from mitochondria into systemic capillary blood, where tissue PCO2 (~46 mmHg) exceeds venous PCO2 (~40 mmHg) sufficiently to drive diffusion.
Step 2 — Hydration and buffering inside the erythrocyte. About 70% of CO2 entering blood diffuses into red blood cells, where the enzyme carbonic anhydrase accelerates the otherwise slow hydration reaction roughly 5,000- to 13,000-fold, converting CO2 + H2O to H2CO3 within a fraction of a second. Carbonic acid dissociates almost completely into H+ and HCO3⁻. The liberated H+ is buffered chiefly by deoxyhemoglobin, whose imidazole groups become better proton acceptors once oxygen is unloaded (the Haldane effect), preventing a catastrophic intracellular pH drop. The HCO3⁻ generated diffuses out of the red cell into plasma via the band 3 anion exchanger, in exchange for a chloride ion moving in — the chloride shift — preserving electroneutrality.
Step 3 — Transport to the lungs. Roughly 90% of blood CO2 is carried as plasma and red-cell bicarbonate, about 5% as dissolved CO2, and about 5% as carbamino compounds bound to hemoglobin's amino groups. In the pulmonary capillaries, the entire sequence reverses: as O2 binds hemoglobin, it displaces H+ (Bohr effect in reverse, i.e., Haldane effect), driving HCO3⁻ back into the red cell (chloride shift reverses) to recombine with H+, re-forming H2CO3, which carbonic anhydrase dehydrates back to CO2 and water. The regenerated CO2 diffuses down its gradient into alveolar gas and is expired.
Step 4 — Ventilatory control of PaCO2. The rate of alveolar ventilation determines how much of this CO2 is actually cleared per minute, according to the alveolar ventilation equation: PaCO2 = (VCO2 × K) / VA where VCO2 is the rate of CO2 production, VA is alveolar ventilation, and K is a constant (~0.863 for standard conditions). This equation is the mechanistic core of respiratory acid-base control: doubling alveolar ventilation halves PaCO2 (all else equal), and halving alveolar ventilation doubles it. Because PaCO2 sets the denominator of the Henderson-Hasselbalch ratio, ventilation is a direct pH lever.
Step 5 — Chemoreceptor feedback. Ventilation itself is not fixed; it is servo-controlled by chemoreceptors that sense the very quantity ventilation regulates.
- Central chemoreceptors, located near the ventral surface of the medulla, do not sense blood pH or PaCO2 directly — they sense the [H+] of the brain extracellular fluid/CSF. Because the blood-brain barrier is far more permeable to CO2 than to H+ or HCO3⁻, a rise in arterial PCO2 causes CO2 to diffuse rapidly into CSF, where it hydrates (CSF has low protein buffering capacity) to lower CSF pH, stimulating these receptors and driving increased ventilation. This pathway accounts for roughly 70-80% of the ventilatory response to a sustained rise in CO2.
- Peripheral chemoreceptors, in the carotid bodies (glomus cells) at the carotid bifurcation and to a lesser degree the aortic bodies, sense arterial PO2 (primarily), PaCO2, and arterial pH directly. They respond faster (seconds) than central chemoreceptors (minutes) and are the only sensors that respond to a pure metabolic acidosis (falling arterial pH with normal or low PaCO2), since central chemoreceptors are relatively insulated from blood pH changes by the blood-brain barrier.
Step 6 — The compensatory loop closes. If a metabolic acid load lowers plasma [HCO3⁻] and pH, peripheral chemoreceptors detect the fall in arterial pH and drive hyperventilation, lowering PaCO2. This partially restores the [HCO3⁻]/PaCO2 ratio toward 20:1 — respiratory compensation — though it can never fully normalize pH because it doesn't restore the lost bicarbonate; only the kidney, over 1-3 days, can regenerate HCO3⁻ and fully correct the disturbance. Symmetrically, a primary respiratory disturbance (e.g., hypoventilation from opioid overdose raising PaCO2) is compensated over days by renal retention of HCO3⁻ (chronic respiratory acidosis) or renal excretion of HCO3⁻ (chronic respiratory alkalosis).
The evidence
Henderson's physical chemistry (1908) and Hasselbalch's clinical extension (1916). Lawrence Henderson, working out the equilibrium chemistry of carbonic acid buffering in blood, derived the mass-action expression relating [H+], [HCO3⁻], and dissolved CO2. Karl Albert Hasselbalch, a Danish physiologist, recast Henderson's equation into logarithmic (pH) form and applied it to blood samples from patients and animals, demonstrating that measured blood pH matched the value predicted from measured [HCO3⁻] and PCO2. This was a critical proof that the CO2/bicarbonate system, not some other unknown buffer, quantitatively accounted for blood's acid-base behavior — and that the equation could be used diagnostically, launching clinical acid-base analysis.
Van Slyke's manometric measurements (1920s). Donald Van Slyke developed precise manometric methods to measure total CO2 content and dissolved CO2 in blood, allowing direct experimental verification of the Henderson-Hasselbalch relationship across a range of physiological and pathological conditions (including diabetic ketoacidosis and renal failure patients). His work established the normal reference ranges — [HCO3⁻] ≈ 24 mmol/L, PaCO2 ≈ 40 mmHg — still used today, and confirmed that changes in blood CO2 tension directly and predictably shift pH according to the equation, without need for additional unknown buffers to explain the data.
Winterstein and the CO2/H+ controversy (1911) — resolved by Gesell and later by direct CSF sampling. Early in the 20th century it was debated whether the respiratory center responds to CO2 itself or to the H+ ions generated from it. Hans Winterstein's "H+ theory" proposed the latter. The definitive resolution came from experiments (extended through the 1950s-60s by researchers including Robert Pappenheimer, Hans Loeschcke, and colleagues) that infused artificial CSF of varied pH and PCO2 directly onto the medullary surface of animals, and separately measured CSF composition across the blood-brain barrier during hypercapnia. These experiments showed CSF pH — not blood pH — tracks the ventilatory response, and that this CSF pH change lags blood PCO2 changes only by the time needed for CO2 (not H+ or HCO3⁻) to cross the blood-brain barrier, since the barrier is far more permeable to CO2. This established that central chemoreceptors are functionally H+-sensitive but physiologically driven by CO2 diffusion into CSF — precisely the "central chemoreceptor" mechanism taught today, and it explained why isolated metabolic acidosis (blood [H+] up, but PaCO2 initially normal) produces a much smaller and slower central ventilatory drive than an equivalent rise in PaCO2.
Carotid body denervation experiments (Heymans and colleagues, 1930s). Corneille Heymans (Nobel Prize, 1938) demonstrated using cross-circulation preparations between dogs that the carotid sinus/body region contains chemosensitive tissue whose nerve signals to the brainstem regulate breathing independent of the central nervous system's direct exposure to blood chemistry. Later work (by investigators including Neil, Biscoe, and others in the 1950s-60s) recorded single-unit action potentials directly from carotid sinus nerve fibers, showing firing rate rises steeply as arterial PO2 falls below ~60 mmHg, and also rises with increased PaCO2 or decreased arterial pH — even when central chemoreceptors were surgically isolated or perfused separately — proving the peripheral chemoreceptors' independent and faster-acting sensitivity to arterial pH itself, the property that makes them essential for detecting metabolic acid-base disturbances.
Clinical validation: the acid-base nomogram and compensation rules. Systematic bedside studies (notably by Horace Davenport, whose 1950s-60s "Davenport diagram" plots pH against [HCO3⁻] and PCO2 iso-bars) compiled thousands of arterial blood gas measurements from patients with known primary disturbances, empirically deriving the expected compensatory response for each disorder (e.g., in chronic respiratory acidosis, [HCO3⁻] rises by roughly 3.5 mmol/L for each 10 mmHg rise in PaCO2). These empirical compensation formulas, still used in every modern arterial blood gas interpretation algorithm, are direct quantitative confirmation that the predicted feedback loop — respiratory system adjusting PaCO2, kidney adjusting HCO3⁻ — operates exactly as the mechanism predicts, and deviation from the expected compensation range is itself the clinical signal of a second, independent acid-base disorder.
Worked examples
Example 1 — Diagnosing a mixed disturbance from arterial blood gas values. A 24-year-old presents with the following arterial blood gas:
| Variable | Value |
|---|---|
| pH | 7.32 |
| PaCO2 | 20 mmHg |
| [HCO3⁻] | 10 mmol/L |
Step 1: pH is low → acidosis is present. Step 2: PaCO2 is low (20 mmHg, normal 40) — by itself this would cause alkalosis, so the low PaCO2 is not the primary problem; it must be a compensatory response. Step 3: [HCO3⁻] is low (10 mmol/L, normal 24) — this is consistent with a primary metabolic acidosis (e.g., diabetic ketoacidosis), and the low PaCO2 represents respiratory compensation (hyperventilation, "Kussmaul breathing") driven by peripheral chemoreceptors sensing the low arterial pH. Step 4: Check whether compensation is "appropriate" using Winter's formula: expected PaCO2 = 1.5×[HCO3⁻] + 8 (±2) = 1.5(10) + 8 = 23 (±2), i.e., expected range 21-25 mmHg. Step 5: Measured PaCO2 (20 mmHg) is slightly below the expected range — this signals a small additional primary respiratory alkalosis is superimposed (perhaps anxiety-driven hyperventilation, or a salicylate-toxicity-like direct stimulation of the medullary respiratory center), making this a mixed acid-base disorder rather than a pure metabolic acidosis with simple compensation. This illustrates the core clinical use of the mechanism: because respiratory compensation for a metabolic disorder is fast but predictably incomplete, quantitative compensation formulas let clinicians detect superimposed disorders that a raw pH value alone would conceal.
Example 2 — Quantifying the ventilatory lever using the alveolar ventilation equation. A patient with chronic obstructive pulmonary disease has alveolar ventilation (VA) of 3.5 L/min and CO2 production (VCO2) of 200 mL/min (typical resting value). Using PaCO2 = (VCO2 × 0.863)/VA: PaCO2 = (200 × 0.863) / 3.5 = 172.6 / 3.5 ≈ 49 mmHg This patient is chronically hypercapnic (normal ≈ 40 mmHg). Suppose over months the kidney compensates fully, raising [HCO3⁻] from 24 to about 27.2 mmol/L (using the chronic compensation rule of +3.5 mmol/L HCO3⁻ per 10 mmHg PaCO2 rise, here for a 9 mmHg rise): expected Δ[HCO3⁻] = 3.5 × (9/10) ≈ 3.15, giving [HCO3⁻] ≈ 27.2 mmol/L. Recomputing pH: pH = 6.1 + log(27.2 / (0.03 × 49)) = 6.1 + log(27.2/1.47) = 6.1 + log(18.5) = 6.1 + 1.267 ≈ 7.37. Notice the ratio (18.5) is close to, but slightly below, the normal 20 — this is exactly why chronic, renally compensated respiratory acidosis leaves pH only mildly below normal (7.37 rather than 7.40) rather than fully corrected: the kidney's job is to shrink the disturbance, not eliminate it, because doing so would require abandoning the buffer ratio the body needs for the next acute perturbation.
Common misconceptions & traps
| Misconception | Correction |
|---|---|
| "The bicarbonate buffer works well because its pKa (6.1) is close to blood pH (7.4)." | It works well despite a mismatched pKa, because the system is open — CO2 is a gas the lungs can continuously remove, unlike a closed buffer at fixed total concentration. |
| "Central chemoreceptors directly sense blood PCO2." | They sense CSF/brain interstitial [H+]; blood PCO2 matters only because CO2 (not H+ or HCO3⁻) crosses the blood-brain barrier freely, then locally generates H+ in CSF. |
| "Hyperventilation always signals a lung problem." | Hyperventilation is frequently a compensatory response to metabolic acidosis (e.g., diabetic ketoacidosis) — the lungs are healthy; they are correcting someone else's problem. |
| "Respiratory compensation fully normalizes pH." | It only partially corrects pH (moves it toward, not to, 7.4); full correction of a metabolic disorder requires renal regeneration or excretion of HCO3⁻ over days. |
| "A normal PaCO2 in a patient with a metabolic acidosis is reassuring." | A "normal" PaCO2 during acute metabolic acidosis is actually inappropriate — expected compensation would have driven PaCO2 down; a normal value may indicate respiratory fatigue or a coexisting respiratory acidosis. |
The scientist behind it
Lawrence Joseph Henderson trained as a physician but spent his career as a physical chemist applying rigorous equilibrium thermodynamics to physiology, at a time when most physiologists worked descriptively rather than quantitatively. He treated blood as a physicochemical system in the tradition of Arrhenius and Ostwald, insisting that its acid-base behavior could be derived from the same mass-action law that governed any weak acid in solution. His 1908 papers on the carbonic acid equilibrium in blood, followed by his influential 1928 book Blood: A Study in General Physiology, reframed acid-base regulation not as a biological mystery but as an elegant application of chemical equilibrium — a conceptual shift that made it possible for clinicians a decade later to read a blood gas report the way an engineer reads a pressure gauge.
Origins · 1 minLawrence Joseph Henderson and how this was discovered
Where this matters today
Arterial blood gas interpretation using the Henderson-Hasselbalch framework and empirical compensation formulas is a routine bedside and ICU tool, used to distinguish primary respiratory from metabolic disturbances and to detect mixed disorders in critically ill patients within minutes. Mechanical ventilator management in respiratory failure is tuned explicitly around this mechanism: adjusting minute ventilation directly titrates PaCO2 and therefore blood pH, and clinicians must anticipate that a ventilated patient with chronic CO2 retention (compensated respiratory acidosis) will develop a dangerous alkalosis if PaCO2 is normalized too quickly, because the renally elevated [HCO3⁻] takes days to fall back down. Understanding of central chemoreceptor CO2-sensing underlies the recognition and management of opioid-induced respiratory depression and central sleep apnea, and informs how supplemental oxygen is titrated cautiously in some patients with chronic hypercapnia. In critical care and nephrology, the compensation rules derived from this mechanism guide recognition of triple acid-base disorders (e.g., a patient with COPD, diarrhea, and sepsis-induced lactic acidosis simultaneously). In exercise physiology and high-altitude medicine, the same feedback loop explains hyperventilation-driven respiratory alkalosis at altitude and its subsequent renal compensation, a bridge directly into Respiratory Adaptations to chronic hypoxia. In anesthesiology, controlled hyperventilation is used to induce therapeutic hypocapnia (lowering intracranial pressure via cerebral vasoconstriction) precisely because of this CO2-pH-ventilation coupling, and in toxicology, salicylate overdose is a classic teaching case of primary respiratory alkalosis (direct medullary stimulation) evolving into a mixed disorder as metabolic acidosis develops.
:::quiz[A patient hyperventilates, lowering PaCO2 from 40 to 25 mmHg with unchanged [HCO3⁻] of 24 mmol/L. What happens to blood pH?]
- pH falls because less dissolved CO2 means less buffering capacity
- pH stays the same because [HCO3⁻] hasn't changed
- pH rises because the [HCO3⁻]/PaCO2 ratio increases above 20:1 ✓
- pH cannot be predicted without knowing the patient's temperature
:::quiz[A patient with chronic respiratory acidosis (elevated PaCO2) has renal compensation that raises [HCO3⁻]. Why does this NOT fully restore pH to exactly 7.40?]
- Because renal compensation actually lowers [HCO3⁻] further
- Because the kidney can only respond to alkalosis, not acidosis
- Because the compensatory rise in [HCO3⁻] only partially restores the 20:1 ratio, not fully ✓
- Because carbonic anhydrase becomes saturated during chronic hypercapnia
Ask the tutor: How would the compensation formulas and ventilatory response differ in an acute versus a chronic respiratory acidosis of the same PaCO2?
Why is CO2, not H+, considered the key variable the respiratory system controls?
Because CO2 is the volatile precursor whose partial pressure the lungs can adjust within minutes by changing alveolar ventilation, whereas free H+ ions cannot be directly "exhaled." The Henderson-Hasselbalch equation shows pH depends on the ratio [HCO3⁻]/PaCO2; ventilation directly sets PaCO2 (the denominator), giving the lungs an immediate lever over pH without needing to handle H+ ions themselves. The kidney, by contrast, manages the numerator ([HCO3⁻]) by reabsorbing filtered bicarbonate and generating new bicarbonate through net acid excretion (as titratable acid and ammonium), a much slower process taking hours to days. This division of labor — fast CO2 control by lungs, slow HCO3⁻ control by kidneys — is why respiratory compensation appears within minutes but renal compensation takes days to reach steady state.
How quickly does respiratory compensation for a metabolic acidosis actually occur?
Peripheral chemoreceptor-driven hyperventilation begins within seconds to minutes of a fall in arterial pH, since carotid body afferents fire rapidly in response to acidemia and relay directly to the medullary respiratory center. Substantial compensation (a measurable fall in PaCO2) is typically evident within 12-24 hours and reaches a new steady state within about 12-24 hours for the respiratory component itself, though the underlying metabolic problem may take longer to resolve. This is dramatically faster than renal compensation for a primary respiratory disorder, which takes 3-5 days to reach a new steady-state bicarbonate level, because renal tubular adaptation (upregulating ammoniagenesis and bicarbonate reabsorption machinery) requires transcriptional and enzymatic changes rather than a simple reflex arc.
What is Winter's formula, and why do clinicians use it?
Winter's formula predicts the expected PaCO2 for a given degree of metabolic acidosis, expressed as expected PaCO2 = 1.5 × [HCO3⁻] + 8 ± 2 (mmHg). It is derived empirically from measurements in patients with pure metabolic acidosis, and it lets clinicians judge whether a patient's respiratory compensation is appropriate. If measured PaCO2 matches the predicted range, the respiratory response is appropriate and only one primary disorder is present. If measured PaCO2 is higher than predicted, an additional primary respiratory acidosis coexists (inadequate compensation); if lower than predicted, an additional primary respiratory alkalosis coexists. This turns a single blood gas measurement into a tool for detecting hidden mixed acid-base disorders.
Can the respiratory system correct a metabolic acid-base disorder completely on its own?
No. Respiratory compensation adjusts PaCO2 to partially restore the [HCO3⁻]/PaCO2 ratio toward 20:1, but it cannot regenerate lost bicarbonate or excrete retained bicarbonate — only the kidney can do that. For example, in diabetic ketoacidosis, hyperventilation lowers PaCO2 and raises pH toward normal, but full correction requires the kidney (and, in treatment, insulin plus fluids) to metabolize the ketoacids and restore bicarbonate stores. This is why respiratory compensation is described as fast but incomplete, while renal compensation (for a primary respiratory disorder) or renal/metabolic correction (for a primary metabolic disorder) is slower but can fully normalize pH given enough time and resolution of the underlying cause.
Why is hyperventilating a metabolic-acidosis patient too aggressively (or ventilating a chronic CO2-retainer to a "normal" PaCO2) dangerous?
In a patient with chronic respiratory acidosis (e.g., severe COPD), the kidney has spent days raising plasma [HCO3⁻] to compensate for chronically elevated PaCO2. If a ventilator suddenly normalizes PaCO2 back to 40 mmHg, the still-elevated [HCO3⁻] is no longer matched by an elevated PaCO2, and the [HCO3⁻]/PaCO2 ratio overshoots above 20:1, producing an acute, sometimes severe, post-hypercapnic metabolic alkalosis. Because renal excretion of the excess bicarbonate takes days, this iatrogenic alkalosis can persist and cause seizures or arrhythmias. The clinical rule is to normalize PaCO2 gradually, matching the patient's own physiological baseline rather than a textbook "normal" value.
How does exercise illustrate the respiratory role in acid-base balance in a healthy person?
During heavy exercise, anaerobic glycolysis generates lactic acid, which dissociates to lactate and H+; the H+ is buffered largely by plasma bicarbonate, consuming HCO3⁻ and generating extra CO2 beyond that from aerobic metabolism alone. Peripheral (and to a lesser extent central, via elevated PaCO2 from the buffering reaction) chemoreceptor input, along with feed-forward neural drive from motor cortex and muscle afferents, increases ventilation disproportionately once the "anaerobic threshold" is crossed, actively lowering PaCO2 below resting levels. This hyperventilation is a real-time respiratory compensation that keeps arterial pH from falling as far as it otherwise would, illustrating the same [HCO3⁻]/PaCO2 ratio mechanism operating on a timescale of seconds during normal physiological stress, not just in disease.
Does the respiratory system ever cause a primary acid-base disturbance rather than just compensating for one?
Yes — any process that changes alveolar ventilation independent of metabolic acid-base status produces a primary respiratory disorder. Opioid overdose, severe COPD, or neuromuscular weakness (e.g., myasthenic crisis) can hypoventilate and raise PaCO2, causing primary respiratory acidosis. Anxiety, pain, high altitude, or direct medullary stimulation (e.g., salicylate toxicity, pregnancy-related progesterone effects) can hyperventilate and lower PaCO2, causing primary respiratory alkalosis. In both cases the kidney is the compensating organ, adjusting bicarbonate reabsorption and net acid excretion over days — the mirror image of the lungs compensating for primary metabolic disorders.